Cervical-vaginal adenosis after in utero exposure to synthetic estrogens.
D000230:Adenocarcinoma / Q000139:chemically induced* / Q000473:pathology; D000293:Adolescent; D000328:Adult; D000466:Alkadienes / Q000009:adverse effects; D004054:Diethylstilbestrol / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D045166:Estradiol Congeners / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005333:Fetus / Q000187:drug effects*; D005500:Follow-Up Studies; D006801:Humans; D008431:Maternal-Fetal Exchange; D009092:Mucous Membrane / Q000473:pathology; D011247:Pregnancy; D002577:Uterine Cervical Diseases / Q000139:chemically induced* / Q000453:epidemiology / Q000473:pathology; D014623:Vaginal Diseases / Q000139:chemically induced*; D014625:Vaginal Neoplasms / Q000139:chemically induced* / Q000473:pathology; D014626:Vaginal Smears
D000466:Alkadienes; D045166:Estradiol Congeners; D004054:Diethylstilbestrol